Neuroprotective effects of some newer and potential antiepileptic drugs

Journal Title: Journal of Pre-Clinical and Clinical Research - Year 2007, Vol 1, Issue 1

Abstract

Experimental models of epilepsy or [i]status epilepticus [/i](SE) provide evidence that seizures result in diffuse brain damage. Other neurological conditions are also associated with neurodegeneration, for example, stroke, head injury and chronic neurodegenerative diseases. In this review, the neuroprotective effects of a number of newer or potential antiepileptic drugs (AEDs) are considered in general in models of experimental epilepsy and ischemia. Among newer AEDs, felbamate, gabapentin, tiagabine and topiramate proved to be neuroprotective agents against seizure, or ischemia-generated neuronal death. The same profile of activity was presented by a potential AED, talampanel. Vigabatrin and levetiracetam were effective against ischemia-induced neurodegeneration, while their effects in seizure models were less consistent. It may be assumed that the neuroprotective effects of AEDs in models of epilepsy or SE may prevent continuous progression of epileptogenesis, thus improving the condition of epileptic patients. However, this possible association may not be that clear. There are data indicating that in spite of clear-cut neuroprotection in models of SE, the subsequent occurrence of spontaneous seizure activity was not prevented. There is also no significant correlation between neuroprotection in experimental ischemia and clinical data. Neuroprotection afforded by AEDs is evident. However, it is not still clear whether this can have a clinically relevant potential. The available clinical data on brain ischemia and AEDs are not encouraging. So far, there are no clinical data whether the neuroprotective effects of AEDs in experimental models of epilepsy possess any impact on the severity of epilepsy. It is possible that AEDs will prove effective in some chronic neurodegenerative diseases.

Authors and Affiliations

Stanisław J. Czuczwar, Renata Ferenc, Barbara Błaszczyk, Kinga K. Borowicz

Keywords

Related Articles

Quercetin: health benefits with relevance to TNF-α-linked inflammatory diseases

With increasing interest among the general public for using natural and herbal remedies, there is a great need to document and list ancient medical texts and practices, as well as to investigate the efficacy of a number...

The influence of cyclosporine A, cyclothiazide and luzindole on the electroconvulsive threshold in mice

The objective of this study was to determine the effect of cyclosporine A (CSA) (a widely used immunosuppressant drug), cyclothiazide (CTZ) (an inhibitor of desensitization of glutamatergic AMPA receptors) and luzindole...

Using PET/CT imaging performance to qualify 18 F-Fluorodeoxy- glucose (FDG) uptake in common carp (Cyprinus carpio)

[b]Introduction.[/b] Positron Emission Tomography (PET) is a non-invasive diagnostic tool that provides tomographic images and measures quantitative parameters of cell viability and metabolic activity of tissues. The mos...

Bioactive diet components and gastrointestinal tract health

Some dietary components that may not be required for human existence may markedly influence the quality of life by modifying physiologic processes. These compounds can influence, in combination or alone, numerous biolog...

A novel biocompatibility test for disperse materials

[b]Introduction[/b]. Development of novel biocompatibility tests represents an urgent problem. Use of chicken embryos minimizes the effect of exogenous factors on the experimental course (as the chicken embryo develops i...

Download PDF file
  • EP ID EP58556
  • DOI -
  • Views 120
  • Downloads 0

How To Cite

Stanisław J. Czuczwar, Renata Ferenc, Barbara Błaszczyk, Kinga K. Borowicz (2007). Neuroprotective effects of some newer and potential antiepileptic drugs. Journal of Pre-Clinical and Clinical Research, 1(1), 1-5. https://europub.co.uk/articles/-A-58556